Role of positron emission tomography in the staging of lung cancer

Lung Cancer

Volumn 17, Issue SUPPL. 1, 1997, Pages

  Schiepers, Christiaan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

FDG (18F fluoro deoxy glucose); Lung cancer; Mediastinal lymphnode staging; Non small cell lung cancer (NSCLC); Positron emission tomography (PET); Solitary lung nodule

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER DIAGNOSIS; CANCER STAGING; CONFERENCE PAPER; DIAGNOSTIC VALUE; HUMAN; LUNG CANCER; LUNG NODULE; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030928295     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(97)00638-7     Document Type: Conference Paper

References (33)

1. Webb WR, Gatsonis C, Zeerhouni EA. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiological Diagnostic Oncology Group. Radiology 1991; 178: 705-713.
2. Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancer: approaching a controversy using meta-analysis. Am Rev Respir Dis 1990; 141: 1096-1101.
3. Dillemans B, Deneffe G, Verschakelen J, Decramer M. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. Eur J Cardio-Thorac Surg 1994; 8: 37-42.
4. Warburg O. The metabolism of tumors. In: Smith RR, editor. New York, 1931: 129-169.
5. Hawkins RA, Hoh CK, Glaspy JA. The role of positron emission tomography in oncology and other whole body applications. Semin Nucl Med 1992; 22: 268-284.
6. 18F]fluoro-2-deoxy-D-glucose. J Comp Assisted Tomogr 1993; 17: 582-589.
7. Nolop KB, Rhodes, Brudin LH. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987; 60: 2682-2689.
8. Kubota K, Matzuzawa TM, Fujiwara T. Differential diagnosis of solitary pulmonary nodules with PET using C-11 methionine. J Comput Assisted Tomogr 1988; 12: 794-796.
9. Knopp MV, Strauss LG, Haberkorn U. PET of the Thorax: assessment of its clinical application in tumor staging. Radiology 1990; 177: 174.
10. Kubota K, Matzuzawa T, Fujiwara T. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990; 31: 1927-1933.
11. Kubota K, Yamada S, Ishiwata K, Ito M, Ido T. Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer. Clin Nucl Med 1992; 17: 877-881.
12. Kubota K, Yamada S, Ishiwata K, Ito M, Fujiwara T, Fukuda H, Tada M, Ido T. Evaluation of the treatment response of lung cancer with positron emission tomography and L-[methyl-11C]methionine: a preliminary study. Eur J Nucl Med 1993; 20: 495-501.
13. Patz EF, Lowe VJ, Hoffman JM. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188: 487-490.
14. Lowe VJ, Hoffman JM, DeLong DM. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35: 1771-1776.
15. Patz EF, Lowe VJ, Hoffman JM. Persistent or recurrent bronchogenic carcinoma: detection with PET and F-18 fluorodeoxyglucose. Radiology 1994; 191: 379-382.
16. Duhaylongsod FG, Lowe VJ, Patz EF Jr. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 FDG-PET. Ann Thorac Surg 1995; 60: 1348-1352.
17. Duhaylongsod FG, Lowe VJ, Patz EF Jr. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995; 110: 130-139 and discussion 139-140.
18. Gupta NC, Frank AR, Dewan NA. Solitary pulmonary nodules: detection of malignancy with PET with FDG. Radiology 1992; 184: 441-444.
19. Dewan NA, Gupta NC, Redepenning LS. Diagnostic efficacy of PET-FDG in solitary pulmonary nodules. Chest 1993; 104: 997-1002.
20. Scott WJ, Schwabe JL, Gupta NC. PET of lung tumors and mediastinal lymph nodes using FDG. Ann Thorac Surg 1994; 58: 698-703.
21. Hubner KF, Buonocore E, Singh SK. Characterization of chest masses by FDG PET. Clin Nucl Med 1995; 20: 293-298.
22. Slosman DO, Spiliopoulos A, Couston F. Satellite PET and lung cancer: a prospective study in surgical patients. Nucl Med Commun 1993; 14: 955-961.
23. Dewan NA, Reeb SD, Gupta NC, Gobar LS, Scott WJ. PET-FDG imaging and trans-thoracic needle lung aspiration biopsy in evaluation of pulmonary lesions: a comparative risk-benefit analysis. Chest 1995; 108: 441-446.
24. Wahl RL, Quint LE, Greenough RL. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-377.
25. Minn H, Zasadny KR, Quint LE, Wahl RL. Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Radiology 1995; 196: 167-173.
26. Sazon DA, Santiago SM, Soo Hoo GW. FDG-PET in the detection and staging of lung cancer. Am J Respir Crit Care Med 1996; 153: 417-421.
27. Chin R Jr, Ward R, Keyes JW. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995; 152: 2090-2096.
28. Rege SD, Hoh CK, Glaspy JA. Imaging of pulmonary mass lesions with whole body PET and FDG. Cancer 1993; 72: 82-90.
29. Lewis P, Griffin S, Marsden P. Whole body FDG PET in pre-operative evaluation of lung cancer. Lancet 1994; 344: 1265-1266.
30. Valk PE, Pounds TR, Hopkins DM. Staging lung cancer by PET imaging. Ann Thorac Surg 1996: (in press).
31. Abe Y, Matzuzawa T, Fujiwara T. Clinical assessment of therapeutic effects on cancer using FDG and PET: preliminary study of lung cancer. Int J Radiat Oncol Biol Phys 1990; 19: 1005-1010.
32. Frank A, Lefkowitz D, Jaeger S. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. Int J Radiat Oncol Biol Phys 1995; 32: 1495-1512.
33. Inoue T, Kim EE, Komaki R. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995; 36: 788-793.